Jiaying L. Wu

No.1095 Jie Fang Avenue
Wuhan, 430030, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

Beyond Remission: Risk-Adapted Maintenance and Mechanism-Guided Salvage After CAR T-Cell Therapy for Multiple Myeloma.

Beyond Remission: Risk-Adapted Maintenance and Mechanism-Guided Salvage After CAR T-Cell Therapy for Multiple Myeloma.

Journal: Stem cell reviews and reports
Published: July 15, 2026

Long-term complete remission and minimal side effects after CD19/CD22 CAR-T cell cocktail therapy in a living donor with DLBCL: A rare case report.

Long-term complete remission and minimal side effects after CD19/CD22 CAR-T cell cocktail therapy in a living donor with DLBCL: A rare case report.

Journal: Cell transplantation
Published: June 03, 2026

Analysis of the efficacy and survival of allogeneic hematopoietic stem cell transplantation and nontransplantation treatment in chronic active Epstein-Barr virus infection.

Analysis of the efficacy and survival of allogeneic hematopoietic stem cell transplantation and nontransplantation treatment in chronic active Epstein-Barr virus infection.

Journal: Cell transplantation
Published: May 30, 2026

Sequential glofitamab and consolidative ASCT plus CAR-T therapy achieved durable remission in relapsed/refractory DLBCL.

Sequential glofitamab and consolidative ASCT plus CAR-T therapy achieved durable remission in relapsed/refractory DLBCL.

Journal: Blood science (Baltimore, Md.)
Published: May 26, 2026

Feasibility of post-induction consolidation with BCMA CAR-T cell therapy in newly diagnosed multiple myeloma not proceeding to ASCT: A preliminary case series.

Feasibility of post-induction consolidation with BCMA CAR-T cell therapy in newly diagnosed multiple myeloma not proceeding to ASCT: A preliminary case series.

Journal: Cell transplantation
Published: May 25, 2026

Advances in immunotherapy for cytomegalovirus infection following allogeneic hematopoietic stem cell transplantation.

Advances in immunotherapy for cytomegalovirus infection following allogeneic hematopoietic stem cell transplantation.

Journal: Immunotherapy
Published: March 19, 2026

Allogeneic hematopoietic stem cell transplantation for the treatment of chronic active Epstein-Barr virus infection.

Allogeneic hematopoietic stem cell transplantation for the treatment of chronic active Epstein-Barr virus infection.

Journal: Cell transplantation
Published: January 31, 2026

MEF2A activates the ZDHHC20/NF-κB pathway to inhibit doxorubicin sensitivity and promote the malignant progression of acute myeloid leukemia.

MEF2A activates the ZDHHC20/NF-κB pathway to inhibit doxorubicin sensitivity and promote the malignant progression of acute myeloid leukemia.

Journal: Biology direct
Published: January 12, 2026

Autologous stem cell transplantation meets CAR-T therapy: A synergistic strategy for B-cell lymphoma.

Autologous stem cell transplantation meets CAR-T therapy: A synergistic strategy for B-cell lymphoma.

Journal: Cell transplantation
Published: October 25, 2025

Acute myeloid leukemia (AML)-derived bone mesenchymal stem cell exosomal METTL14 promotes AML cell growth and glycolysis by HOXA3/WNT7B axis.

Acute myeloid leukemia (AML)-derived bone mesenchymal stem cell exosomal METTL14 promotes AML cell growth and glycolysis by HOXA3/WNT7B axis.

Journal: Cell biology and toxicology
Published: October 10, 2025

Targeting GPRC5D With CAR-T Cells in Relapse/Refractory Multiple Myeloma: Case Report and Literature Review.

Targeting GPRC5D With CAR-T Cells in Relapse/Refractory Multiple Myeloma: Case Report and Literature Review.

Journal: Case reports in hematology
Published: July 08, 2025

Mesenchymal Stromal Cells: Bridging the Gaps in Hematologic Disease Therapy.

Mesenchymal Stromal Cells: Bridging the Gaps in Hematologic Disease Therapy.

Journal: Stem cell reviews and reports
Published: May 29, 2025
Showing 1-12 of 28

Last Updated: 09/26/2026